., the p.b.m. is t happy,he drug is covered on the formulary. unfortunately for all of us, drug prices go up. >> it's, it's, it's rather a startling and perverse system that has, that has evolved over time. >> reporter: secretahealth and human services alex azar testified in june before the senate health committee about the president's drug pricing plan.th azar saiadministration is considering regulatory changes that would allow rebates to be scrutinized der federal anti- kickback laws. >> we may need to move toward a rebates, where mab.m.s receive no compensation from the very phompanies that they are supposed to be negotiating against. r orter: azar, a former pharmaceutical executive, also said he's heard reports ofth p.b.m.atening drugmakers. >> we've had several drug i companies cowho are-- want to execute substantial material reductions in their drug prices. they are finding hurdles from pharmacy benefit managers and stributors, where they might say, "well, if you decreased your list price, i

owns one of the largest the biggest p.b.m. care mark in theory p.b.m. is mediate between drug makers pharmacies employers and insurance plans in order to shake out savings and pocket a portion of what they find their role was enhanced by the affordable care act but in recent years p b m's have been criticized by some as profit taking millman c.e.o. marlow said the real culprit in the steadily rising prices for lifesaving drugs are not p.b.s. but manufacturer rebates mr brewer told reporters on an earnings call yesterday that our data show that the list price for increasing faster for drugs with smaller rebates than it is for medications with substantial rebates c.b.s. the second quarter revenue was reported forty six point seven billion dollars with thirty three billion in revenue from caremark their c. subsidiary caremark revenue was up two point six eight percent outpacing two point two percent overall growth in c.v.s. revenue. breaking news today we've spoken before about the sinclair broadcast group which made local anchors some silly script about be

owns one of the largest the biggest p.b.m. caremark in theory p.b.m. is mediate between drug makers pharmacies employers and insurance plans in order to shake out savings and pocket a portion of what they find their role was enhanced by the affordable care act but in recent years p b m's have been criticized by some as profit taking millman c.e.o. marlo said the real culprit in the steadily rising prices for lifesaving drugs are not p.b.s. but manufacturer rebates mr brewer told reporters on an earnings call yesterday that our data show that the list price for increasing faster for drugs with smaller rebates than it is for medications with substantial rebates c.b.s. the second quarter revenue was reported forty six point seven billion dollars with thirty three billion in revenue from caremark their c. subsidiary caremark revenue was up two point six eight percent outpacing two point two percent overall growth in c.v.s. revenue. i. in breaking news today we've spoken before about the sinclair broadcast group which made local anchors for some silly script